Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway

Gut

Volumn 66, Issue 11, 2017, Pages 1900-1911

  Wang, Ting Ting ^a   Zhao, Yong Liang ^a   Peng, Liu Sheng ^a   Chen, Na ^a   Chen, Weisan ^b   Lv, Yi Pin ^a   Mao, Fang Yuan ^a   Zhang, Jin Yu ^a   Cheng, Ping ^a   Teng, Yong Sheng ^a   Fu, Xiao Long ^a   Yu, Pei Wu ^a   Guo, Gang ^a   Luo, Ping ^a   Zhuang, Yuan ^a   Zou, Quan Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE; PROGRAMMED DEATH 1 LIGAND 1; STAT3 PROTEIN; CD274 PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STAGING; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; KAPLAN MEIER METHOD; LEUKOCYTE ACTIVATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; T LYMPHOCYTE; ANIMAL; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MORTALITY; MOUSE; NONOBESE DIABETIC MOUSE; SCID MOUSE; STOMACH TUMOR; SURVIVAL RATE;

ANIMALS; ANTIGENS, CD274; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNE TOLERANCE; KAPLAN-MEIER ESTIMATE; MICE; MICE, INBRED NOD; MICE, SCID; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 85030084646     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-313075     Document Type: Article

References (24)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263-74.
3. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013;19:1423-37.
4. Wu Y, Zhao Q, Peng C, et al. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol 2011;225: 438-47.
5. Graziosi L, Marino E, De Angelis V, et al. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer. Am J Surg 2015;209:333-7.
6. Zhao JJ, Pan K, Wang W, et al. The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One 2012;7:e33655.
7. Zhuang Y, Peng LS, Zhao YL, et al. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer Immunol Immunother 2012;61:1965-75.
8. Li XF, Chen DP, Ouyang FZ, et al. Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma. J Hepatol 2015;62:131-9.
9. Fortunati E, Kazemier KM, Grutters JC, et al. Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol 2009;155:559-66.
10. Zhuang Y, Peng LS, Zhao YL, et al. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 2012;143:951-62.e8.
11. Kuang DM, Zhao Q, Peng C, et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 2009;206:1327-37.
12. Bowers NL, Helton ES, Huijbregts RP, et al. Immune suppression by neutrophils in HIV-1 infection: Role of PD-L1/PD-1 pathway. PLoS Pathog 2014;10: E1003993.
13. de Kleijn S, Langereis JD, Leentjens J, et al. IFN-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1. PLoS ONE 2013;8: E72249.
14. Sippel TR, White J, Nag K, et al. Neutrophil degranulation and immunosuppression in patients with GBM: Restoration of cellular immune function by targeting arginase I. Clin Cancer Res 2011;17:6992-7002.
15. Dufait I, Schwarze JK, Liechtenstein T, et al. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer. Oncotarget 2015;6:12369-82.
16. Allavena P, Sica A, Garlanda C, et al. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 2008;222:155-61.
17. Fridlender ZG, Sun J, Kim S, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009;16:183-94.
18. Piccard H, Muschel RJ, Opdenakker G. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol 2012;82:296-309.
19. Shojaei F, Singh M, Thompson JD, et al. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci USA 2008;105:2640-5.
20. Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 2014;124:5466-80.
21. Hercus TR, Broughton SE, Ekert PG, et al. The GM-CSF receptor family: Mechanism of activation and implications for disease. Growth Factors 2012;30:63-75.
22. Urdinguio RG, Fernandez AF, Moncada-Pazos A, et al. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors. Cancer Res 2013;73:395-405.
23. Lammel V, Stoeckle C, Padberg B, et al. Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung. Lung Cancer 2012;76:493-5.
24. Aliper AM, Frieden-Korovkina VP, Buzdin A, et al. A role for G-CSF and GM-CSF in nonmyeloid cancers. Cancer Med 2014;3:737-46